In The Spotlight
DDNews Cancer Research Exclusive
Here's to more survivors
(Photo credit: National Cancer Institute)
Recent reports from cancer advocacy and research organizations detail an increase in cancer survivors, with incidence and mortality rates dropping in recent years
LipoMedix announces publication of positive Phase 1 data for Promitil in Investigational New Drugs
Chi-Med candidate for advanced pancreatic neuroendocrine tumors meets primary endpoint ahead of schedule
UC San Diego team identifies the molecule that allows Zika to enter brain cells—a discovery that could also lead to a new way to target brain cancer cells
Researchers discover that extracellular vesicles can help melanoma spread
Femtogenix payload platform has favorable toxicity profile
BioLineRx’s combination regimen leads to improved disease control in pancreatic cancer
BioLineRx Ltd. recently announced preliminary data from its Phase 2a COMBAT/KEYNOTE-202 study
A Phase 2 trial of Transgene’s TG4010 in combination with chemotherapy and Opdivo failed to reach its primary endpoint of overall response rate
Glioblastoma remains a difficult cancer to treat, but the brain malignancy is seeing increasing attention in R&D
by Martin Lachs/Brandon Fletcher
As excitement and investment related to adoptive cell transfer products increases, there are concerns and issues that need to be addressed in terms of long-term follow-up trials

by Sue Cramp, Charles River
In pursuit of new options for treating childhood cancers, a new approach to drug discovery and development may be an answer

by Andrea Toell of Lonza
Andrea Toell of Lonza shares how CAR T cells are transforming immuno-oncology

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.